For respiratory infection testing, clinical labs must adapt quickly to changing needs based on seasonal demand, as well as patient age and overall health. With significant overlap of symptoms across infections and an evolving reimbursement landscape, labs must have flexibility in assays to deliver high-quality, cost-effective results.
Whether you need high-volume influenza assays or a broad selection of targets, we can help.
Luminex offers the most scalable, flexible respiratory disease testing portfolio to assist labs with managing the needs of physicians, patients, and the overall healthcare system. Our molecular diagnostic assays allow you to adjust target selection and sample throughput for maximum testing accuracy, cost efficiency, and clinical impact.
Learn more about our respiratory disease testing options:
|Which Test is Right for You?|
|Assay||ARIES® Flu A/B & RSV Assay||ARIES® Bordetella Assay||NxTAG® Respiratory Pathogen Panel||VERIGENE® Respiratory Pathogens Flex Test|
|Instruments||ARIES® Systems||ARIES® Systems||MAGPIX® (NxTAG‑enabled)||VERIGENE® System|
|2 hours||2 hours||5 hours||2 hours|
per 24 samples
|Throughput||Low – Medium||Low – Medium||High||Low – Medium|
Flu Season Hits Epidemic Levels — Luminex Blog
For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/regions. Please contact Luminex at [email protected] to obtain the appropriate product information for your country of residence.